Standing at the precipice of a biotech renaissance – the confluence of AI and SynBio
The coming together of two of the most transformative technologies of our age will shine a light on our manipulation of biological systems.
Most Popular
US government backs thymus rejuvenation project with $37m ARPA-H funding
Thymus Rejuvenation project led by Thymmune Therapeutics aims to restore damaged or non-functional thymus tissue.
‘Data-driven health is going to be the biggest revolution in the history of medicine’
The Buck and Phenome Health join forces on a data-driven approach to understanding aging biology and improving human healthspan.
Researchers land $3.2m to study impact of microbiome disruption on Alzheimer’s
Researchers at the University of Alabama to investigate the effects of microbiome disruption on Alzheimer’s disease progression.
Will psychedelics produce the next longevity drug?
Dr Halland Chen on longevity medicine, mindset and the potential of psychedelics to improve human longevity.
Supplements
NMN Bio and Aster Pharmacy unite to bring antiaging supplements to UAE market
Partnership aims to set a new standard for health and wellness in the United Arab Emirates.
Editor's pick
US government backs thymus rejuvenation project with $37m ARPA-H funding
Thymus Rejuvenation project led by Thymmune Therapeutics aims to restore damaged or non-functional thymus tissue.
Novo Nordisk Foundation’s new €127m cell therapy facility targets chronic disease
Foundation has committed up to €127 million to establish a cutting-edge facility dedicated to advancing cell therapies for chronic disease.
Investors from around the world gather in Gstaad
Longevity.Technology's CEO reports from Day 1 of the Longevity Investors Conference in Switzerland.
Vincere lands grant funding for research into mitophagy enhancing Parkinson’s drug
Grant will support research aimed at evaluating the efficacy of Vincere's mitophagy enhancing inhibitor molecule in Parkinson's disease.
Watch now
‘I want medical tourism to be open to everyone, forever’
BioViva's CEO Liz Parrish on de-risking regulatory systems and creating evidence-based medicine from medical tourism.
Physicians want AI tech to help dementia patients live longer
Two-thirds of UK GPs want to prescribe tech for their dementia patients to help them remain independent and live longer.
Connected technologies are changing the future of aging at home
Huong Le Dieu, Lead Product Manager of BLabs at Baracoda Daily Healthtech, on why it's time to take aging in place to the next level.
AI innovations to transform living with dementia awarded £1.9 million
Longitude Prize on Dementia champions personalized tech that to helps people living with dementia enjoy independent and fulfilled lives.
Clearday and Viveon Health SPAC announce merger agreement to accelerate innovative longevity tech
Definitive merger agreement set to accelerate robotic companion care/AI longevity tech platform to market.
